Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00572260 · ClinicalTrials.gov registry record · Phase 4

A Pilot Study of Daptomycin for Antimicrobial Prophylaxis

A Phase 4 study, sponsored by Duke University.

Terminated
Registry status
Phase 4
Development phase
11
Enrollment target

NCT00572260: Clinical Trial Phase 4 study, sponsored by Duke University.

NCT00572260 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 11 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00572260, a Phase 4 study, was terminated before completion, sponsored by Duke University.

TERMINATED
Registry status
Phase 4
Development phase
11 participants
Enrollment target

Study Summary

The goals of the study are to evaluate the feasibility of using daptomycin as a prophylactic antimicrobial agent in patients undergoing cardiac surgery, to determine the rates of surgical site infection, and to evaluate the occurrence of adverse events.

Interventions

  • DRUG daptomycin 6 mg/kg IV

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2008-01
Est. Completion 2008-09
Phase Phase 4
Duke University

1,725 total trials

Why NCT00572260 stopped before completion

NCT00572260 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which daptomycin 6 mg/kg IV is the first listed.

NCT00572260 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00572260 about?

NCT00572260 is a clinical study titled "A Pilot Study of Daptomycin for Antimicrobial Prophylaxis". The goals of the study are to evaluate the feasibility of using daptomycin as a prophylactic antimicrobial agent in patients undergoing cardiac surgery, to determine the rates of surgical site infection, and to evaluate the occurrence of adverse events.

What is the current status of trial NCT00572260?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2008-01. Estimated completion is 2008-09.

What interventions are being tested in trial NCT00572260?

The interventions under investigation include: daptomycin 6 mg/kg IV (DRUG).

Who is sponsoring clinical trial NCT00572260?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00572260's enrollment target sits among peer trials

11 1931st of 2000 higher than 61 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00572260, the US trial registry maintained by the National Library of Medicine. NCT00572260 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.